person · Reporting owner

O'Meara Maeve

Disclosed activity across 2 companies

Tapewire entity: 95778
SEC CIK: 0001742487

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Starling Oncology, Inc.TOI · Entity 5327	Director	December 26, 2023	December 28, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Starling Oncology, Inc.

Report date December 26, 2023 · Filed December 28, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common stockSEC Table I · non-derivative	Direct	109,104	Reported balance After 2023-12-26 transaction · row 1 1 source row Row 1 · 2023-12-26 · Grant · Acquired 50,000 · Balance 109,104 F1: Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

CASTLIGHT HEALTH, INC.

Report date January 12, 2022 · Filed February 18, 2022

Section 16 reporting ended · disclosed 2022-02-18. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class B Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2022-02-17 transaction · row 1 1 source row Row 1 · 2022-02-17 · Disposition to issuer · Disposed 1,625,989 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger (the "Surviving Corporation"), as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time.
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	397,500	Reported balance After 2022-01-12 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-01-12 · Grant · Acquired 397,500 · Balance 397,500 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F3: 1/3 of the RSUs vested on February 16, 2022 and the remainder will vest quarterly over two years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-02-17 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2022-02-17 · Disposition to issuer · Disposed 12,500 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F4: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-02-17 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2022-02-17 · Disposition to issuer · Disposed 25,000 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F6: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-02-17 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2022-02-17 · Disposition to issuer · Disposed 115,313 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F7: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-02-17 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2022-02-17 · Disposition to issuer · Disposed 301,725 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F8: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-02-17 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2022-02-17 · Disposition to issuer · Disposed 558,000 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F9: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-02-17 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2022-02-17 · Disposition to issuer · Disposed 430,625 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F10: 1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Restricted Stock Units (RSU)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-02-17 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2022-02-17 · Disposition to issuer · Disposed 397,500 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F3: 1/3 of the RSUs vested on February 16, 2022 and the remainder will vest quarterly over two years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.09 · Expires 2022-11-07	Direct	0	Reported balance After 2022-02-17 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2022-02-17 · Disposition to issuer · Disposed 9,000 · Balance 0 F14: Pursuant to the Merger Agreement, the option was cancelled and converted at or immediately prior to the Effective Time into a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option. F11: The stock option is fully vested and immediately exercisable. F12: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date. F13: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.12 · Expires 2023-02-11	Direct	0	Reported balance After 2022-02-17 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2022-02-17 · Disposition to issuer · Disposed 7,500 · Balance 0 F14: Pursuant to the Merger Agreement, the option was cancelled and converted at or immediately prior to the Effective Time into a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option. F11: The stock option is fully vested and immediately exercisable. F12: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date. F13: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.35 · Expires 2023-10-24	Direct	0	Reported balance After 2022-02-17 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2022-02-17 · Disposition to issuer · Disposed 20,000 · Balance 0 F15: The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time. F11: The stock option is fully vested and immediately exercisable. F12: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date. F13: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.99 · Expires 2026-02-23	Direct	0	Reported balance After 2022-02-17 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2022-02-17 · Disposition to issuer · Disposed 155,000 · Balance 0 F15: The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time. F11: The stock option is fully vested and immediately exercisable.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.01 · Expires 2030-03-02	Direct	0	Reported balance After 2022-02-17 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2022-02-17 · Disposition to issuer · Disposed 331,000 · Balance 0 F17: Pursuant to the Merger Agreement, to the extent vested, the option was cancelled and converted at or immediately prior to the Effective Time into the right to receive a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option. To the extent unvested, the option was cancelled and converted at or immediately prior to the Effective Time into the right to receive a cash replacement amount equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option cash equivalent award valued based on the excess of the Merger Consideration over the option exercise price (the "Option Consideration"). [continued in fn 18]. F18: [cont. from fn. 17] The payment of the Option Consideration will be subject to vesting in accordance with the vesting schedule applicable to the unvested portion of the option immediately prior to the Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F16: The option vested as to 1/5th of the total number of shares on March 3, 2021, and thereafter vests as to 1/36th monthly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger (the "Surviving Corporation"), as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time.

F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration.

F3: 1/3 of the RSUs vested on February 16, 2022 and the remainder will vest quarterly over two years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

F4: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date.

F6: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

F7: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

F8: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

F9: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

F10: 1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

F11: The stock option is fully vested and immediately exercisable.

F12: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date.

F13: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time.

F14: Pursuant to the Merger Agreement, the option was cancelled and converted at or immediately prior to the Effective Time into a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option.

F15: The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time.

F16: The option vested as to 1/5th of the total number of shares on March 3, 2021, and thereafter vests as to 1/36th monthly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

F17: Pursuant to the Merger Agreement, to the extent vested, the option was cancelled and converted at or immediately prior to the Effective Time into the right to receive a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option. To the extent unvested, the option was cancelled and converted at or immediately prior to the Effective Time into the right to receive a cash replacement amount equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option cash equivalent award valued based on the excess of the Merger Consideration over the option exercise price (the "Option Consideration"). [continued in fn 18].

F18: [cont. from fn. 17] The payment of the Option Consideration will be subject to vesting in accordance with the vesting schedule applicable to the unvested portion of the option immediately prior to the Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 26, 2023 Filed Dec 28, 2023 21:58 UTC	Starling Oncology, Inc. TOI · Entity 5327	GrantCommon stock	50,000	$0.00	$0.00	Disclosure SEC source: 0001628280-23-042815 · wk-form4_1703800674.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,104 F1 · price: Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date. Read SEC document
March 17, 2023 Filed Mar 22, 2023 00:49 UTC	Starling Oncology, Inc. TOI · Entity 5327	GrantCommon stock	16,404	$0.00	$0.00	Disclosure SEC source: 0001628280-23-008829 · wf-form4_167944617091630.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,104 F1 · shares: Represents restricted stock units that vest in full on March 16, 2024, subject to continued service with the Company through such vesting date. Read SEC document
November 17, 2022 Filed Nov 21, 2022 22:33 UTC	Starling Oncology, Inc. TOI · Entity 5327	GrantCommon Stock	22,708	$0.00	$0.00	Disclosure SEC source: 0001799191-22-000038 · edgardoc.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,700 F1 · price: Represents restricted stock units that vest in full on May 17, 2023, subject to continued service with the Company through such vesting date. Read SEC document
March 21, 2022 Filed Mar 23, 2022 23:36 UTC	Starling Oncology, Inc. TOI · Entity 5327	GrantCommon stock	3,998	$0.00	$0.00	Disclosure SEC source: 0001628280-22-007100 · wf-form4_164807857979175.xml · nonDerivative · entry 2 O'Meara Maeve · CIK 0001742487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,992 Read SEC document
March 21, 2022 Filed Mar 23, 2022 23:36 UTC	Starling Oncology, Inc. TOI · Entity 5327	GrantCommon stock	15,994	$0.00	$0.00	Disclosure SEC source: 0001628280-22-007100 · wf-form4_164807857979175.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,994 F1 · shares: Represents restricted stock units that vest in full on November 12, 2022, subject to continued service with the Company through such vesting date. F1 · price: Represents restricted stock units that vest in full on November 12, 2022, subject to continued service with the Company through such vesting date. Read SEC document
February 17, 2022 Filed Feb 18, 2022 14:10 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	331,000	Not disclosed Strike: $1.01	Not disclosed	Disclosure SEC source: 0001209191-22-011149 · doc4.xml · derivative · entry 14 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 331,000 shares Expires 2030-03-02 F17 · price: Pursuant to the Merger Agreement, to the extent vested, the option was cancelled and converted at or immediately prior to the Effective Time into the right to receive a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option. To the extent unvested, the option was cancelled and converted at or immediately prior to the Effective Time into the right to receive a cash replacement amount equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option cash equivalent award valued based on the excess of the Merger Consideration over the option exercise price (the "Option Consideration"). [continued in fn 18]. F18 · price: [cont. from fn. 17] The payment of the Option Consideration will be subject to vesting in accordance with the vesting schedule applicable to the unvested portion of the option immediately prior to the Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F16 · derivative.exercise_date: The option vested as to 1/5th of the total number of shares on March 3, 2021, and thereafter vests as to 1/36th monthly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
February 17, 2022 Filed Feb 18, 2022 14:10 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	155,000	Not disclosed Strike: $2.99	Not disclosed	Disclosure SEC source: 0001209191-22-011149 · doc4.xml · derivative · entry 13 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 155,000 shares Expires 2026-02-23 F15 · price: The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time. F11 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document
February 17, 2022 Filed Feb 18, 2022 14:10 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	20,000	Not disclosed Strike: $2.35	Not disclosed	Disclosure SEC source: 0001209191-22-011149 · doc4.xml · derivative · entry 12 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 20,000 shares Expires 2023-10-24 F15 · price: The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time. F11 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. F12 · derivative.underlying: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date. F13 · derivative.underlying: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time. Read SEC document
February 17, 2022 Filed Feb 18, 2022 14:10 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	7,500	Not disclosed Strike: $1.12	Not disclosed	Disclosure SEC source: 0001209191-22-011149 · doc4.xml · derivative · entry 11 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 7,500 shares Expires 2023-02-11 F14 · price: Pursuant to the Merger Agreement, the option was cancelled and converted at or immediately prior to the Effective Time into a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option. F11 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. F12 · derivative.underlying: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date. F13 · derivative.underlying: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time. Read SEC document
February 17, 2022 Filed Feb 18, 2022 14:10 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Disposition to issuerEmployee Stock Option (right to buy) · Derivative	9,000	Not disclosed Strike: $1.09	Not disclosed	Disclosure SEC source: 0001209191-22-011149 · doc4.xml · derivative · entry 10 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 9,000 shares Expires 2022-11-07 F14 · price: Pursuant to the Merger Agreement, the option was cancelled and converted at or immediately prior to the Effective Time into a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option. F11 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. F12 · derivative.underlying: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date. F13 · derivative.underlying: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time. Read SEC document
February 17, 2022 Filed Feb 18, 2022 14:10 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Disposition to issuerRestricted Stock Units (RSU) · Derivative	397,500	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-22-011149 · doc4.xml · derivative · entry 9 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 397,500 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5 · price: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F3 · derivative.exercise_date: 1/3 of the RSUs vested on February 16, 2022 and the remainder will vest quarterly over two years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F3 · derivative.expiration_date: 1/3 of the RSUs vested on February 16, 2022 and the remainder will vest quarterly over two years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
February 17, 2022 Filed Feb 18, 2022 14:10 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Disposition to issuerRestricted Stock Units (RSU) · Derivative	430,625	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-22-011149 · doc4.xml · derivative · entry 8 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 430,625 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5 · price: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F10 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F10 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
February 17, 2022 Filed Feb 18, 2022 14:10 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Disposition to issuerRestricted Stock Units (RSU) · Derivative	558,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-22-011149 · doc4.xml · derivative · entry 7 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 558,000 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5 · price: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F9 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F9 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
February 17, 2022 Filed Feb 18, 2022 14:10 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Disposition to issuerRestricted Stock Units (RSU) · Derivative	301,725	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-22-011149 · doc4.xml · derivative · entry 6 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 301,725 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5 · price: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F8 · derivative.exercise_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F8 · derivative.expiration_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
February 17, 2022 Filed Feb 18, 2022 14:10 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Disposition to issuerRestricted Stock Units (RSU) · Derivative	115,313	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-22-011149 · doc4.xml · derivative · entry 5 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 115,313 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5 · price: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F7 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F7 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
February 17, 2022 Filed Feb 18, 2022 14:10 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Disposition to issuerRestricted Stock Units (RSU) · Derivative	25,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-22-011149 · doc4.xml · derivative · entry 4 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 25,000 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5 · price: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F6 · derivative.exercise_date: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F6 · derivative.expiration_date: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
February 17, 2022 Filed Feb 18, 2022 14:10 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Disposition to issuerRestricted Stock Units (RSU) · Derivative	12,500	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-22-011149 · doc4.xml · derivative · entry 3 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 12,500 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5 · price: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F4 · derivative.exercise_date: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F4 · derivative.expiration_date: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
February 17, 2022 Filed Feb 18, 2022 14:10 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Disposition to issuerClass B Common Stock	1,625,989	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-22-011149 · doc4.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger (the "Surviving Corporation"), as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time. Read SEC document
January 12, 2022 Filed Feb 18, 2022 14:10 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	GrantRestricted Stock Units (RSU) · Derivative	397,500	$0.00	$0.00	Disclosure SEC source: 0001209191-22-011149 · doc4.xml · derivative · entry 2 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,500 Underlying: Class B Common Stock · 397,500 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: 1/3 of the RSUs vested on February 16, 2022 and the remainder will vest quarterly over two years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F3 · derivative.expiration_date: 1/3 of the RSUs vested on February 16, 2022 and the remainder will vest quarterly over two years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
November 17, 2021 Filed Nov 18, 2021 19:56 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	SaleClass B Common Stock	99,009	$1.77	$175,513.25	Disclosure SEC source: 0001209191-21-065650 · doc4.xml · nonDerivative · entry 7 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,625,989 F1 · kind: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.755 to $1.83 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
November 16, 2021 Filed Nov 18, 2021 19:56 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	33,125	$0.00	$0.00	Disclosure SEC source: 0001209191-21-065650 · doc4.xml · derivative · entry 13 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,625 Underlying: Class B Common Stock · 33,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F9 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F9 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
November 16, 2021 Filed Nov 18, 2021 19:56 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	62,000	$0.00	$0.00	Disclosure SEC source: 0001209191-21-065650 · doc4.xml · derivative · entry 12 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558,000 Underlying: Class B Common Stock · 62,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F8 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F8 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
November 16, 2021 Filed Nov 18, 2021 19:56 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	43,103	$0.00	$0.00	Disclosure SEC source: 0001209191-21-065650 · doc4.xml · derivative · entry 11 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,725 Underlying: Class B Common Stock · 43,103 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F7 · derivative.exercise_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F7 · derivative.expiration_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
November 16, 2021 Filed Nov 18, 2021 19:56 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	23,062	$0.00	$0.00	Disclosure SEC source: 0001209191-21-065650 · doc4.xml · derivative · entry 10 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,313 Underlying: Class B Common Stock · 23,062 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F6 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F6 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
November 16, 2021 Filed Nov 18, 2021 19:56 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-065650 · doc4.xml · derivative · entry 9 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class B Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5 · derivative.exercise_date: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F5 · derivative.expiration_date: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
November 16, 2021 Filed Nov 18, 2021 19:56 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-065650 · doc4.xml · derivative · entry 8 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Class B Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F4 · derivative.expiration_date: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
November 16, 2021 Filed Nov 18, 2021 19:56 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	33,125	$0.00	$0.00	Disclosure SEC source: 0001209191-21-065650 · doc4.xml · nonDerivative · entry 6 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,724,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 16, 2021 Filed Nov 18, 2021 19:56 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	62,000	$0.00	$0.00	Disclosure SEC source: 0001209191-21-065650 · doc4.xml · nonDerivative · entry 5 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,691,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 16, 2021 Filed Nov 18, 2021 19:56 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	43,103	$0.00	$0.00	Disclosure SEC source: 0001209191-21-065650 · doc4.xml · nonDerivative · entry 4 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,629,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 16, 2021 Filed Nov 18, 2021 19:56 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	23,062	$0.00	$0.00	Disclosure SEC source: 0001209191-21-065650 · doc4.xml · nonDerivative · entry 3 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,586,770 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 16, 2021 Filed Nov 18, 2021 19:56 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-065650 · doc4.xml · nonDerivative · entry 2 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,563,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 16, 2021 Filed Nov 18, 2021 19:56 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-065650 · doc4.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,551,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
October 08, 2021 Filed Oct 8, 2021 19:12 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	ConversionClass A Common Stock · Derivative	5,000	$0.00	$0.00	Disclosure SEC source: 0001209191-21-060117 · doc4.xml · derivative · entry 4 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.exercise_price: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. F1 · derivative.exercise_date: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.exercise_date: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. F1 · derivative.expiration_date: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.expiration_date: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. Read SEC document
October 08, 2021 Filed Oct 8, 2021 19:12 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass A Common Stock · Derivative	5,000	$0.00	$0.00	Disclosure SEC source: 0001209191-21-060117 · doc4.xml · derivative · entry 3 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Class B Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.exercise_price: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. F1 · derivative.exercise_date: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.exercise_date: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. F1 · derivative.expiration_date: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.expiration_date: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. Read SEC document
October 08, 2021 Filed Oct 8, 2021 19:12 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionEmployee Stock Option (right to buy) · Derivative	5,000	$0.00 Strike: $0.85	$0.00	Disclosure SEC source: 0001209191-21-060117 · doc4.xml · derivative · entry 2 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,000 shares Expires 2021-10-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option has fully vested and is immediately exercisable. F1 · derivative.underlying: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · derivative.underlying: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. Read SEC document
October 08, 2021 Filed Oct 8, 2021 19:12 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	ConversionClass B Common Stock	5,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-21-060117 · doc4.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,538,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of issuer's Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date. F2 · price: Each share of the issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. Read SEC document
August 17, 2021 Filed Aug 17, 2021 20:01 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	SaleClass B Common Stock	99,975	$1.71	$170,887.27	Disclosure SEC source: 0001209191-21-052086 · doc4.xml · nonDerivative · entry 7 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,533,708 F1 · kind: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.665 to $1.815 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document
August 16, 2021 Filed Aug 17, 2021 20:01 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	33,125	$0.00	$0.00	Disclosure SEC source: 0001209191-21-052086 · doc4.xml · derivative · entry 13 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 463,750 Underlying: Class B Common Stock · 33,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F9 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F9 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
August 16, 2021 Filed Aug 17, 2021 20:01 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	62,000	$0.00	$0.00	Disclosure SEC source: 0001209191-21-052086 · doc4.xml · derivative · entry 12 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 620,000 Underlying: Class B Common Stock · 62,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F8 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F8 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
August 16, 2021 Filed Aug 17, 2021 20:01 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	43,104	$0.00	$0.00	Disclosure SEC source: 0001209191-21-052086 · doc4.xml · derivative · entry 11 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,828 Underlying: Class B Common Stock · 43,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F7 · derivative.exercise_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F7 · derivative.expiration_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
August 16, 2021 Filed Aug 17, 2021 20:01 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	23,063	$0.00	$0.00	Disclosure SEC source: 0001209191-21-052086 · doc4.xml · derivative · entry 10 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,375 Underlying: Class B Common Stock · 23,063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F6 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F6 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
August 16, 2021 Filed Aug 17, 2021 20:01 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-052086 · doc4.xml · derivative · entry 9 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Class B Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5 · derivative.exercise_date: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F5 · derivative.expiration_date: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
August 16, 2021 Filed Aug 17, 2021 20:01 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionRestricted Stock Units (RSU) · Derivative	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-052086 · doc4.xml · derivative · entry 8 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class B Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F4 · derivative.expiration_date: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document
August 16, 2021 Filed Aug 17, 2021 20:01 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	33,125	$0.00	$0.00	Disclosure SEC source: 0001209191-21-052086 · doc4.xml · nonDerivative · entry 6 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,633,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 16, 2021 Filed Aug 17, 2021 20:01 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	62,000	$0.00	$0.00	Disclosure SEC source: 0001209191-21-052086 · doc4.xml · nonDerivative · entry 5 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 16, 2021 Filed Aug 17, 2021 20:01 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	43,104	$0.00	$0.00	Disclosure SEC source: 0001209191-21-052086 · doc4.xml · nonDerivative · entry 4 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,538,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 16, 2021 Filed Aug 17, 2021 20:01 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	23,063	$0.00	$0.00	Disclosure SEC source: 0001209191-21-052086 · doc4.xml · nonDerivative · entry 3 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,495,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 16, 2021 Filed Aug 17, 2021 20:01 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-052086 · doc4.xml · nonDerivative · entry 2 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,472,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 16, 2021 Filed Aug 17, 2021 20:01 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	Exercise / conversionClass B Common Stock	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-052086 · doc4.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,459,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 17, 2021 Filed May 18, 2021 18:55 UTC	CASTLIGHT HEALTH, INC. CSLT · Entity 130187	SaleClass B Common Stock	76,439	$1.61	$123,158.52	Disclosure SEC source: 0001209191-21-033727 · doc4.xml · nonDerivative · entry 7 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,447,391 F1 · kind: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.54 to $1.74 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.